Cara A. Rosenbaum

Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma

Philip L. McCarthy, Kouros Owzar, Craig C. Hofmeister et al. · New England Journal of Medicine · 2012 · 1.1K citations · Full text

Widespread Genetic Heterogeneity in Multiple Myeloma: Implications for Targeted Therapy

Jens G. Lohr, Petar Stojanov, Scott L. Carter et al. · Cancer Cell · 2014 · 988 citations · Full text

Hematological Malignancy, Disease Heterogeneity, Widespread Genetic Heterogeneity +7

Clinical features associated with COVID-19 outcome in multiple myeloma: first results from the International Myeloma Society data set

Ajai Chari, Mehmet Samur, Joaquín Martínez‐López et al. · Blood · 2020 · 181 citations · Full text

Phase III Intergroup Study of Lenalidomide Versus Placebo Maintenance Therapy Following Single Autologous Hematopoietic Stem Cell Transplantation (AHSCT) for Multiple Myeloma: CALGB 100104

Philip L. McCarthy, Kouros Owzar, Kenneth C. Anderson et al. · Blood · 2010 · 78 citations

Carfilzomib, lenalidomide, and dexamethasone plus transplant in newly diagnosed multiple myeloma

Jagoda Jasielec, Tadeusz Kubicki, Noopur Raje et al. · Blood · 2020 · 72 citations · Full text